Steven Fletcher

4.0k total citations
110 papers, 3.3k citations indexed

About

Steven Fletcher is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Steven Fletcher has authored 110 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 89 papers in Molecular Biology, 34 papers in Organic Chemistry and 30 papers in Oncology. Recurrent topics in Steven Fletcher's work include Chemical Synthesis and Analysis (20 papers), Protein Degradation and Inhibitors (17 papers) and Cell death mechanisms and regulation (14 papers). Steven Fletcher is often cited by papers focused on Chemical Synthesis and Analysis (20 papers), Protein Degradation and Inhibitors (17 papers) and Cell death mechanisms and regulation (14 papers). Steven Fletcher collaborates with scholars based in United States, Canada and United Kingdom. Steven Fletcher's co-authors include Patrick T. Gunning, Andrew D. Hamilton, Edward V. Prochownik, Jeremy L. Yap, James Turkson, Lijia Chen, Maryanna E. Lanning, Jay Chauhan, Peibin Yue and Xiaolei Zhang and has published in prestigious journals such as Angewandte Chemie International Edition, Blood and Biomaterials.

In The Last Decade

Steven Fletcher

105 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steven Fletcher United States 35 2.2k 1.1k 980 249 239 110 3.3k
Thorsten Berg Germany 31 2.3k 1.0× 575 0.5× 1.5k 1.5× 270 1.1× 479 2.0× 93 3.6k
A.E. Prota Switzerland 33 2.6k 1.2× 1.5k 1.4× 935 1.0× 185 0.7× 199 0.8× 72 4.2k
László Őrfi Hungary 31 1.6k 0.7× 539 0.5× 1.0k 1.1× 155 0.6× 335 1.4× 113 3.3k
Peter L. Toogood United States 27 1.6k 0.7× 752 0.7× 1.5k 1.5× 223 0.9× 215 0.9× 55 3.6k
Gregory H. Bird United States 32 3.5k 1.6× 701 0.7× 701 0.7× 117 0.5× 313 1.3× 59 4.1k
Paul A. Sprengeler United States 32 1.9k 0.8× 1.8k 1.7× 449 0.5× 214 0.9× 194 0.8× 82 3.6k
Gordon W. Rewcastle New Zealand 35 2.4k 1.1× 2.4k 2.2× 1.2k 1.2× 116 0.5× 186 0.8× 107 4.7k
Jennifer L. Meagher United States 33 2.2k 1.0× 453 0.4× 708 0.7× 115 0.5× 349 1.5× 53 2.9k
Marina Protopopova United States 34 1.9k 0.8× 1.9k 1.8× 853 0.9× 117 0.5× 218 0.9× 66 4.6k
John S. McMurray United States 31 1.6k 0.7× 551 0.5× 1.1k 1.1× 199 0.8× 539 2.3× 79 2.8k

Countries citing papers authored by Steven Fletcher

Since Specialization
Citations

This map shows the geographic impact of Steven Fletcher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Fletcher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Fletcher more than expected).

Fields of papers citing papers by Steven Fletcher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven Fletcher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Fletcher. The network helps show where Steven Fletcher may publish in the future.

Co-authorship network of co-authors of Steven Fletcher

This figure shows the co-authorship network connecting the top 25 collaborators of Steven Fletcher. A scholar is included among the top collaborators of Steven Fletcher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven Fletcher. Steven Fletcher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Tulapurkar, Mohan E., Kari Ann Shirey, Wendy Luo, et al.. (2024). First-in-class mitogen-activated protein kinase (MAPK) p38α: MAPK-activated protein kinase 2 dual signal modulator with anti-inflammatory and endothelial-stabilizing properties. Journal of Pharmacology and Experimental Therapeutics. 392(3). 100031–100031. 2 indexed citations
3.
Fletcher, Steven, et al.. (2023). Multimodal nanoparticle‐containing modified suberoylanilide hydroxamic acid polymer conjugates to mitigate immune dysfunction in severe inflammation. Bioengineering & Translational Medicine. 9(1). e10611–e10611. 6 indexed citations
4.
Fontana, Francesca, Michael J. Scott, John S. Allen, et al.. (2020). VLA4-Targeted Nanoparticles Hijack Cell Adhesion–Mediated Drug Resistance to Target Refractory Myeloma Cells and Prolong Survival. Clinical Cancer Research. 27(7). 1974–1986. 19 indexed citations
5.
Esser, Alison K., Michael H. Ross, Francesca Fontana, et al.. (2020). Nanotherapy delivery of c-myc inhibitor targets Protumor Macrophages and preserves Antitumor Macrophages in Breast Cancer. Theranostics. 10(17). 7510–7526. 31 indexed citations
6.
Kazi, Aslamuzzaman, Shengyan Xiang, Hua Yang, et al.. (2019). Dual Farnesyl and Geranylgeranyl Transferase Inhibitor Thwarts Mutant KRAS-Driven Patient-Derived Pancreatic Tumors. Clinical Cancer Research. 25(19). 5984–5996. 53 indexed citations
7.
Chauhan, Jay, et al.. (2019). Optimization of a small-molecule Lipid II binder. Bioorganic & Medicinal Chemistry Letters. 29(14). 1849–1853.
8.
Yang, Shyh‐Ming, Daniel J. Urban, Makoto Yoshioka, et al.. (2018). Discovery and lead identification of quinazoline-based BRD4 inhibitors. Bioorganic & Medicinal Chemistry Letters. 28(21). 3483–3488. 13 indexed citations
9.
Whiting, E. E., et al.. (2017). Discovery of Mcl-1 inhibitors based on a thiazolidine-2,4-dione scaffold. Bioorganic & Medicinal Chemistry Letters. 28(3). 523–528. 15 indexed citations
10.
11.
Fletcher, Steven & Edward V. Prochownik. (2014). Small-molecule inhibitors of the Myc oncoprotein. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1849(5). 525–543. 120 indexed citations
12.
Jupiter, Daniel C., Steven Fletcher, Jeremy L. Yap, et al.. (2012). The downregulation of Mcl-1 via USP9X inhibition sensitizes solid tumors to Bcl-xl inhibition. BMC Cancer. 12(1). 541–541. 70 indexed citations
13.
Yap, Jeremy L., Xiaobo Cao, Kenno Vanommeslaeghe, et al.. (2012). Relaxation of the rigid backbone of an oligoamide-foldamer-based α-helix mimetic: identification of potent Bcl-xL inhibitors. Organic & Biomolecular Chemistry. 10(15). 2928–2928. 54 indexed citations
14.
Mitra, Rajendra Narayan, Xiaolei Zhang, Niclas E. Bengtsson, et al.. (2011). An activatable multimodal/multifunctional nanoprobe for direct imaging of intracellular drug delivery. Biomaterials. 33(5). 1500–1508. 48 indexed citations
15.
Fletcher, Steven, Xiaolei Zhang, Peibin Yue, et al.. (2009). Disruption of Transcriptionally Active Stat3 Dimers with Non‐phosphorylated, Salicylic Acid‐Based Small Molecules: Potent in vitro and Tumor Cell Activities. ChemBioChem. 10(12). 1959–1964. 70 indexed citations
16.
Liu, Baoxu, et al.. (2009). A Photostable, pH-Invariant Fluorescein Derivative for Single-Molecule Microscopy. Journal of Fluorescence. 19(5). 915–920. 30 indexed citations
17.
Fletcher, Steven, James Turkson, & Patrick T. Gunning. (2008). Molecular Approaches towards the Inhibition of the Signal Transducer and Activator of Transcription 3 (Stat3) Protein. ChemMedChem. 3(8). 1159–1168. 88 indexed citations
18.
Fletcher, Steven, et al.. (2007). Protein-Protein Interaction Inhibitors: Small Molecules from Screening Techniques. Current Topics in Medicinal Chemistry. 7(10). 922–927. 54 indexed citations
19.
Wilson, Andrew J., Jason Hong, Steven Fletcher, & Andrew D. Hamilton. (2006). Recognition of solvent exposed protein surfaces using anthracene derived receptors. Organic & Biomolecular Chemistry. 5(2). 276–285. 31 indexed citations
20.
Fletcher, Steven & Andrew D. Hamilton. (2005). Protein surface recognition and proteomimetics: mimics of protein surface structure and function. Current Opinion in Chemical Biology. 9(6). 632–638. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thorsten Berg Breakdown of academic impact, for papers by A.E. Prota Breakdown of academic impact, for papers by László Őrfi Breakdown of academic impact, for papers by Peter L. Toogood Breakdown of academic impact, for papers by Gregory H. Bird Breakdown of academic impact, for papers by Paul A. Sprengeler Breakdown of academic impact, for papers by Gordon W. Rewcastle Breakdown of academic impact, for papers by Jennifer L. Meagher Breakdown of academic impact, for papers by Marina Protopopova Breakdown of academic impact, for papers by John S. McMurray
Rankless by CCL
2026